[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
JAMA Diagnostic Test Interpretation
December 24/31, 2014

Parathyroid Hormone in the Evaluation of Hypercalcemia

Author Affiliations
  • 1Division of Endocrinology, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York
JAMA. 2014;312(24):2680-2681. doi:10.1001/jama.2014.9195

A 54-year-old woman was incidentally noted to have hypercalcemia on routine testing. She feels well and reports no concerns. She underwent total thyroidectomy 15 years earlier for papillary thyroid cancer and is taking levothyroxine suppression therapy without evidence of recurrence. Serum calcium levels before her thyroidectomy were normal. She has well-controlled hypertension and hyperlipidemia. Her other medications include losartan, atorvastatin, and ezetimibe. She has no history of low trauma fractures (occurring from falls at standing height or less) or nephrolithiasis. She has no family history of hypercalcemia. Physical examination demonstrated no palpable thyroid tissue. Her laboratory values are reported in the Table.

First Page Preview View Large
First page PDF preview
First page PDF preview
×